Placeholder Banner

BIO Statement: Mexico's New Decree Falls Short

February 14, 2023
Media Contact
Lynne Headshot

Mexico’s new decree creates more questions than answers.

The decree still wrongly calls into question the safety of products of agricultural biotechnology for human consumption by creating a non-science-based distinction of corn used for food and corn used for feed and industrial uses.

The decree also does not provide any commitment that Mexico’s regulators will return to a science- and risk-based regulatory approval process for all agricultural biotechnology products in the future.

BIO appreciates the U.S. government’s ongoing efforts to hold Mexico to its USMCA commitments and its recent request that Mexico provide the justification behind its past decree on biotech corn and the rejections of new biotech seed traits. While BIO has supported dialogue to resolve this issue, it has become necessary for USTR to request consultations with Mexico over its treatment of agricultural biotechnology in order to provide a framework and timeline to resolve this issue.

Discover More
Urges Congress to support rare disease patients & support the billWASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after…
WASHINGTON, D.C. (January 17, 2025) – The Biotechnology Innovation Organization (BIO) today released the following statement after the Biden administration released a list of 15 medicines being selected for government price setting:“In the final…
Today the dispute settlement panel formed under the United States-Mexico-Canada Agreement (USMCA) issued a final ruling related to Mexico's restrictions on the importation of genetically modified (GM) corn. In response, John Crowley, President…